Dietary fiber, protein intake, and regular exercise do modestly increase endogenous GLP-1 secretion
Clinical trials show that GLP-1 agonists reduce hunger sensation within days, though maximum weight-loss benefits typically emerge over 1216 weeks
MOTS-Cs anti-aging properties combined with the metabolic reset from significant Retatrutide-driven weight loss create a protocol that touches on multiple longevity markers simultaneously
All pregnancies have a risk of birth defect, loss, or other adverse outcomes
Tirzepatide is a dual agonist that activates GIP and GLP-1 receptors
Depressive-like behavior In male rodents, supplementation with vitamin E (P31-45) [104] or folic acid (P41-61) [41] reversed the POS-induced depressive-like behavior measured in the FST at P6061 [41] and at P45-47 [104], but not in the splash test (ST) at P45-47 [104]